Skip to content

Effect of Daily Steps on Fat Metabolism

Effect of Daily Ambulatory Activity on the Responses to Acute Aerobic Exercise.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03697382
Enrollment
12
Registered
2018-10-05
Start date
2018-09-29
Completion date
2020-05-31
Last updated
2021-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Metabolic Syndrome

Brief summary

Reduced ambulatory activity has been shown to effect the response to a high fat tolerance test (HFTT) after acute exercise. This study will evaluate the effect of varying levels of daily ambulation on response to a HFTT after an acute aerobic exercise bout.

Interventions

BEHAVIORALVery Low Steps

Subjects will have a 2-day control period during which step count and diet will be controlled for and recreated for the other trials. Following this 2-day period, they will undergo the Very Low Stepping trial with the acute bout of exercise on day 2. Day 3 will consist of the lipid tolerance test to determine the ability of the body to clear triglycerides.

BEHAVIORALLow Steps

Subjects will have a 2-day control period during which step count and diet will be controlled for and recreated for the other trials. Following this 2-day period, they will undergo the Low Stepping trial with the acute bout of exercise on day 2. Day 3 will consist of the lipid tolerance test to determine the ability of the body to clear triglycerides.

BEHAVIORALModerate Steps

Subjects will have a 2-day control period during which step count and diet will be controlled for and recreated for the other trials. Following this 2-day period, they will undergo the Moderate Stepping trial with the acute bout of exercise on day 2. Day 3 will consist of the lipid tolerance test to determine the ability of the body to clear triglycerides.

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Subjects will complete three experimental conditions which include 2 days of reduced step count (2,500, 5,000, and 7,500 steps/day) with 1-hour of exercise at 65% VO2max.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Exclusion criteria

* Cardiovascular problems (e.g. pre-existing heart issues, coronary artery disease, hypertension, etc.) * Respiratory problems * Musculoskeletal problems that prevent prolonged sitting or exercise * Obesity * Susceptibility to fainting * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
6-Hour Plasma Triglyceride Area Under the Curve6-hoursAreas under the curve for triglyceride concentration will be calculated for hourly samples from a 6-hour lipid tolerance test.

Secondary

MeasureTime frameDescription
6-Hour Plasma Insulin Area Under the Curve6-hoursAreas under the curve for insulin concentration will be calculated for hourly samples from a 6-hour lipid tolerance test
6-Hour Plasma Glucose Area Under the Curve6-hoursAreas under the curve for glucose concentration will be calculated for hourly samples from a 6-hour lipid tolerance test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026